BCYC vs PSX · rev $1.5M vs P/E 17, rev $83.54B
Bicycle Therapeutics Ltd (BCYC) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
BCYC currently screens at market cap $554.0M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the BCYC and PSX stock pages for the full models.
Not investment advice.